FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Zydus Pharmaceuticals Pramipexole Dihydrochoride Tablets 0 Recall

Pramipexole Dihydrochoride Tablets 0

Zydus Pharmaceuticals USA Inc · Pennington, NJ

Risk level
Class II
Reported by FDA
Jun 26, 2019
Recall ID
D-1444-2019
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals recalled Pramipexole Dihydrochoride Tablets 0 starting May 6, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1444-2019 on Jun 26, 2019. Reason: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure. Status: Terminated.

Why it was recalled

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Product description

Pramipexole Dihydrochoride Tablets 0.25 mg, 90-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-197-16

Lot numbers, UPCs & expiration codes

Lots: M706802, M706804, M706907, M706909, M707028, EXP May-19; M714180, M714181, EXP Oct-19; M717063, M717064, M801705, M801706, M801707, M801708, M714923, M714924, M714925 EXP Dec-19; M808307, M808308, M808309, M808310, EXP May-20; M812479, M812481, M812482, M812483, EXP Jul-20; M815787 M815789, M815790, M815791, M815788, EXP Sep-20; M820266, M820267, M820268, M820269, M820265 EXP Nov-20; M903040, M903041, M903042 EXP Jan-21.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1444-2019
Classification
Class II
Status
Terminated
Recall initiated
May 6, 2019
FDA report date
Jun 26, 2019
Quantity
215,760 90-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals USA Inc

Original FDA data

Every field from FDA enforcement report D-1444-2019, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Terminated
Country
United States
Event ID
82827
Address
73 Route 31 N
Code information
Lots: M706802, M706804, M706907, M706909, M707028, EXP May-19; M714180, M714181, EXP Oct-19; M717063, M717064, M801705, M801706, M801707, M801708, M714923, M714924, M714925 EXP Dec-19; M808307, M808308, M808309, M808310, EXP May-20; M812479, M812481, M812482, M812483, EXP Jul-20; M815787 M815789, M815790, M815791, M815788, EXP Sep-20; M820266, M820267, M820268, M820269, M820265 EXP Nov-20; M903040, M903041, M903042 EXP Jan-21.
Postal code
08534-3601
Report date
Jun 26, 2019
Product type
Drugs
Recall number
D-1444-2019
Classification
Class II
Recalling firm
Zydus Pharmaceuticals USA Inc
Product quantity
215,760 90-count bottles
Termination date
Sep 16, 2021
Reason for recall
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pramipexole Dihydrochoride Tablets 0.25 mg, 90-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-197-16
Distribution pattern
Nationwide in the USA
Recall initiation date
May 6, 2019
Initial firm notification
Letter
Center classification date
Jul 1, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1444-2019, published Jun 26, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls